(VIANEWS) – The Market ended the session with NYXOAH (NYXH.BR) rising 11.55% to €4.25 on Friday while BEL 20 jumped 0.11% to €3,556.71.
NYXOAH’s last close was €3.81, 58.86% below its 52-week high of €9.26.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.76%.
Volume
Today’s last reported volume for NYXOAH is 14604 which is 26.95% below its average volume of 19993.
More news about NYXOAH (NYXH.BR).
